<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00419640</url>
  </required_header>
  <id_info>
    <org_study_id>CR04032AF</org_study_id>
    <nct_id>NCT00419640</nct_id>
  </id_info>
  <brief_title>SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation</brief_title>
  <acronym>SAFE</acronym>
  <official_title>Septal Pacing for Atrial Fibrillation Suppression Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, parallel, single-blinded multi-center study. The objective is to
      compare the long term clinical outcomes among the site of atrial pacing and to compare the
      long term effect of the atrial fibrillation (AF) Suppression algorithm.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2005</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Persistent AF and chronic AF</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Device diagnostic data: number of atrial high rate episode, mode switch episode and AF burden</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of cardioversions</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety and efficacy of low septal pacing</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiogram (Echo) parameters include left ventricular ejection fraction (LVEF) and diastolic index using Doppler Echo</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality-of-life questionnaire: Short Form-36 (SF-36)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major cardiovascular events: heart failure, stroke, hospitalization, and cardiovascular mortality</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">385</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>LAS + DAO ON</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The right atrial lead is placed in the low atrial septal position and the DAO algorithm is turned ON.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LAS + DAO OFF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The right atrial lead is placed in the low atrial septal position and the DAO algorithm is turned OFF.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RAA + DAO ON</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The right atrial lead is placed in the right atrial appendage position and the DAO algorithm is turned ON.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RAA + DAO OFF</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The right atrial lead is placed in the right atrial appendage position and the DAO algorithm is turned OFF.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pacemaker implantation with RA lead in LAS position</intervention_name>
    <description>Pacemaker implantation with RA lead placed in low atrial septal position</description>
    <arm_group_label>LAS + DAO ON</arm_group_label>
    <other_name>Identity ADx DR device</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pacemaker implantation with RA lead in LAS position</intervention_name>
    <description>Pacemaker implantation with RA lead placed in low atrial septal position</description>
    <arm_group_label>LAS + DAO OFF</arm_group_label>
    <other_name>Identity ADx DR pacemaker</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pacemaker implantation with RA lead in RAA position</intervention_name>
    <description>Pacemaker implantation with RA lead placed in right atrial appendage position</description>
    <arm_group_label>RAA + DAO ON</arm_group_label>
    <other_name>Identity ADx DR pacemaker</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pacemaker implantation with RA lead in RAA position</intervention_name>
    <description>Pacemaker implantation with RA lead placed in right atrial appendage position</description>
    <arm_group_label>RAA + DAO OFF</arm_group_label>
    <other_name>Identity ADx DR pacemaker</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Have a history of paroxysmal AF with documented AF episode within the last 6 months;
             documentation of AF is required. It can be documented by one of the following:

               -  Holter documentation and the strip must be at least 30 seconds; OR

               -  one page of 12-lead electrocardiogram (ECG); OR

               -  transtelephonic recording for more than 15 seconds.

          2. Have a conventional indication for a pacemaker due to either sinus or atrioventricular
             (AV) node diseases.

          3. Provide written informed consent for study participation and be willing and able to
             comply with the prescribed follow-up tests and schedule of evaluations.

          4. Be at least 18 years old.

        Exclusion Criteria:

          1. Already implanted with a pacemaker or implantable cardioverter defibrillator (ICD).

          2. Are expected to have heart surgery within the next 6 months.

          3. Have angina pectoris, New York Heart Association (NYHA) Class III or Class IV.

          4. Are expected not to be able to tolerate high rate pacing.

          5. Have less than 12 months' life expectancy.

          6. Are on the cardiac transplantation list.

          7. Are in chronic AF.

          8. Have a reversible aetiology of AF (e.g., hyperthyroidism, acute post-cardiac surgery
             AF, etc.).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chu-Pak Lau, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Hong Kong</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Queen Mary Hospital, The University Hospital of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2007</study_first_submitted>
  <study_first_submitted_qc>January 8, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2007</study_first_posted>
  <last_update_submitted>December 12, 2012</last_update_submitted>
  <last_update_submitted_qc>December 12, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 13, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sinus node disease</keyword>
  <keyword>AV node disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

